DigestAID

DIGESTAID is an enterprise focused on the development of Artificial Intelligence solutions for application to several fields of digestive endoscopy. Our main drive was to overcome the diagnostic limit

DigestAID has secured several partnerships with large medical centers all over the world, which will enable safe access to a large volume and variety of data, which is essential for the development of AI algorithms, including in Portugal, Spain, France, Brazil, and United States of America.
Centro Hospitalar Universitário de São João (Porto, Portugal): l
- ManopH Gastroenterology Clinic (Porto, Portugal)
- Hôpital Paris Saint-Joseph (Paris, France)
- Hospital Universitário Puerta de Hierro Majadahonda (Madrid, Spain)
- Clinica Pelvia (Curitiba, Brasil)
- NYU Langone Hospital (NY, USA)

The prevalence of digestive diseases is rising and accounts for significant morbidity and mortality. Current diagnostic methods in gastroenterology are often cumbersome, inefficient, and with suboptimal performance.

Our AI solutions were proposed to address these diagnostic limitations by the application of AI, to optimize the detection and differentiation of lesions across the gastrointestinal tract.

DigestAID aims to operate mainly on a B2B. DigestAID’s business model ensures a cost-effective solution for medical centers and hospitals of different sizes based on a carefully constructed pricing model determined by assessment of 5 EU countries. We have already secured the participation of the relevant stakeholders needed for the successful commercialization (validation sites, CROs and the development and regulatory support needed for the future scale-up): the focus now will be on securing further CE distributors, thus engaging more hospitals/medical centers as early adopters.

Endless Frontier Labs